Fri, 02 Oct 2020 15:55:47 BST
The University of Glasgow is joining a global five-year program to understand and address threats posed by zoonotic viral diseases that can “spill over” from animals to humans, such as SARS-CoV-2, in an effort to reduce risk of infection, amplification, and spread.
Community led response to COVID-19 in Colombia
Animal African Trypanosomiasis
Lyme disease in the Scottish Western Isles
Capacity strengthening projects in Africa
- SARS-CoV-2 infections in cats: assessing their zoonotic potential and role in sustaining the pandemic; BBSRC, £337k (2020-22)
- A One Health Approach to Understanding the Epidemiology of Crimean-Congo Haemorrhagic Fever virus in Tanzania; US Department of Defense, £41k (2021-22).
- Developing and applying technology to investigate babesiosis, an emerging disease in Scotland; Medical Research Scotland, £121k (2020-24).
- Development of next generation anti-malarials targeting the essential parasite protein kinase PfCLK3; MRC, £688k (2020-22).
- Deciphering developmental commitment in African trypanosomes using single-cell transcriptomics; Wellcome Trust, £30k (2020-22).
- Pioneering UofG researcher recognised by Royal Society of Edinburgh
- Six UofG academics recognised in Queen's birthday honours
- UofG part of new UK Coronavirus immunology consortium to address key unanswered questions about immunity and COVID-19
- Researchers identify evolutionary origins of SARS-COV-2
- Scientists identify cat infected with SARS-COV-2 in the UK
- Malaria mosquito research could provide new control tools
- Risk of viruses emerging in humans may not depend on their animal host
- Zoonotic causes of febrile illness in malaria endemic countries: a systematic review. Science Direct (2020)
- Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic. Nature Microbiology (2020)
- A microsporidian impairs Plasmodium falciparum transmission in Anopheles arabiensis mosquitoes. Nature (2020)
- Viral zoonotic risk is homogenous among taxonomic orders of mammalian and avian reservoir hosts. PNAS (2020)
- Establishment of Wolbachia Strain wAlbB in Malaysian Populations of Aedes aegypti for Dengue Control. Current Biology (2019)
Glasgow is an international leader in One Health research.
We seek to improve human and animal health by addressing questions that arise as a result of the many and diverse interdependencies between these two domains.
One Health approaches cannot be confined to the study of either human or veterinary medicine, or even to a combination of the two. Instead, the effective resolution of health questions depends critically on understanding the complex biological and social, economic, political and environmental contexts in which those questions are embedded. With the growing recognition of the importance of multimorbidity, this area of research has expanded to include the study of interactions between infectious and non-communicable disease.
These complex issues are most powerfully addressed through interdisciplinary collaborations. At Glasgow, researchers from human and veterinary clinical medicine are closely integrated with life scientists, and interface with social and physical scientists to deliver world-changing research. We work both across the Global South with a focus on sub-Saharan Africa, particularly Tanzania and Malawi, and in Scotland and the rest of the UK.
Our collaborations have made a significant impact on key national, global health and veterinary agendas.